[Treatment of a large intracoronary thrombus with urokinase and a chimeric monoclonal platelet aggregation inhibitor]

Dtsch Med Wochenschr. 1997 May 30;122(22):709-15. doi: 10.1055/s-2008-1047678.
[Article in German]

Abstract

History and clinical findings: 7 days after an operation for intervertebral disc prolapse a 43-year-old man was referred with the clinical and ECG signs of an acute posterior wall myocardial infarction.

Investigations: Creatine kinase (CK) activity was raised to 204 U/I (myocardial-specific isoenzyme CKMB of 23.6 U/I, 11.6% of total) and glutamic-oxalate transferase (GOT) activity to 37 U/I. Emergency cardiac catheterisation, performed 4 hours after renewed onset of precordial pain showed no abnormal findings in the right coronary artery, despite the ECG signs, but a definite filling defect in the anterior interventricular branch, which on intravascular ultrasound was an echo-dense noncalcified structure.

Treatment and course: After percutaneous transluminal coronary angioplasty in the area of the obstructing structure a free-floating mass was identified in the proximal part of the anterior interventricular branch, most likely a thrombus. Intercoronary thrombolysis was therefore undertaken with urokinase (bolus of 1 mill. IU) together with the chimeric monoclonal antibody c7E3, which inhibits platelet aggregation by blocking the platelet glycoprotein surface receptor IIb/IIIa. Coronary angiography 12 hours later revealed almost complete dissolution of the previously obstructing mass.

Conclusion: Combining the platelet aggregation inhibitor c7E3 with a thrombolytic agent is an alternative treatment to the current management of intracoronary thrombi. Intravascular ultrasound is a suitable method for demonstrating angiographically inconspicuous or unclear but pathogenetically significant vessel changes.

Publication types

  • Case Reports

MeSH terms

  • Abciximab
  • Adult
  • Angioplasty, Balloon, Coronary
  • Antibodies, Monoclonal / therapeutic use*
  • Coronary Angiography
  • Coronary Thrombosis / drug therapy*
  • Diagnosis, Differential
  • Electrocardiography
  • Humans
  • Immunoglobulin Fab Fragments / therapeutic use*
  • Intervertebral Disc Displacement / surgery
  • Lumbar Vertebrae
  • Male
  • Plasminogen Activators / therapeutic use*
  • Platelet Aggregation Inhibitors / therapeutic use*
  • Postoperative Complications / therapy
  • Thrombolytic Therapy*
  • Urokinase-Type Plasminogen Activator / therapeutic use*

Substances

  • Antibodies, Monoclonal
  • Immunoglobulin Fab Fragments
  • Platelet Aggregation Inhibitors
  • Plasminogen Activators
  • Urokinase-Type Plasminogen Activator
  • Abciximab